Rajnish Wellness Limited (BOM:541601)
0.4400
-0.0100 (-2.22%)
At close: Jun 17, 2026
Rajnish Wellness Revenue
In the fiscal year ending March 31, 2026, Rajnish Wellness had annual revenue of 1.43B INR with 193.60% growth. Rajnish Wellness had revenue of 1.02B in the quarter ending March 31, 2026, with 1,665.59% growth.
Revenue
1.43B
Revenue Growth
+193.60%
P/S Ratio
0.31
Revenue / Employee
83.87M
Employees
17
Market Cap
446.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.43B | 940.15M | 193.60% |
| Mar 31, 2025 | 485.61M | -281.24M | -36.67% |
| Mar 31, 2024 | 766.85M | 508.59M | 196.93% |
| Mar 31, 2023 | 258.26M | -6.11M | -2.31% |
| Mar 31, 2022 | 264.37M | 130.08M | 96.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Mangalam Drugs & Organics | 2.32B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Sandu Pharmaceuticals | 699.35M |
| Shelter Pharma | 598.96M |
| Panjon | 476.21M |